Accounts Payable

9 Months Ended

Sep. 30, 2022

Accounts Payable

Accounts Payable

5.            Accounts Payable

As of September 30, 2022, current liabilities included accounts payable of $1.0 million, comprised primarily of amounts owed for clinical trial expenses of $0.4 million, drug supply manufacturing of $0.4 million and legal and patent fees of $0.2 million. As of December 31, 2021, current liabilities included accounts payable of $0.1 million, comprised primarily of legal and patent fees and expenses related to manufacturing totaling $0.1 million.